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Background:  A hypointense core (HC) of infarcted myocardium in T2-weighted CMR has been used as a noninvasive marker for intramyocardial 
hemorrhage and was related with adverse remodelling in recently published clinical trials. However, the clinical significance of such findings is not 
yet established. Aim of this study was to evaluate determinants and prognostic impact of a HC in T2-weighted CMR images, studied in patients after 
acute, reperfused STEMI.
Methods:  We analyzed 346 STEMI patients undergoing primary angioplasty <12 h after symptom onset at 2 institutions in Germany and Canada. 
T2-weighted and contrast-enhanced CMR was used for assessment of the area-at-risk, myocardial salvage, infarct size, HC in T2-weighted images 
and late microvascular obstruction (MO). Patients were categorized into 3 groups defined by the presence or absence of a HC and also MO. Primary 
endpoint of the study was occurrence of MACE defined as death, reinfarction and congestive heart failure within 6 months.
Results: There were 3 groups of patients; patients with HC plus MO (n=122), patients without HC with MO (n=108), and patients without HC 
and without MO (n=116). The extent of infarct size (r=0.61) and late MO (r=0.74) correlated significantly with the volumetric extent of the HC 
(p<0.001, respectively). In a multivariable regression model adjusted for significant variables in univariable regression analysis, the extent of late MO 
(p<0.001), infarct size (p=0.01), and impaired ejection fraction (p=0.02) were the strongest predictors of HC.
The presence of a HC was a strong univariable and multivariable predictor of MACE (hazard ratio: 2.59, confidence interval: 1.27-5.27). When using 
a 3-level categorical variable including 1) MO and HC both present 2) MO only present; 3) No MO and no HC present, a risk gradient across the 3 
groups could be observed (16.4% versus 10.8% versus 3.6%, p=0.002).
Conclusions: A HC within the area at risk of reperfused infarcted myocardium in T2-weighted CMR is closely related to infarct size, MO and 
impaired left ventricular function with subsequent adverse clinical outcome.
